Stockholders’ Equity and Share-Based Compensation (Tables)

12 Months Ended

Dec. 31, 2022

Equity [Abstract]

Schedule of share-based compensation expense

	Year Ended December 31, 2022		Year Ended December 31, 2021
Research and development	$	123,652	$	498,913
General and administrative		171,471		809,095
Total	$	295,123	$	1,308,008

Schedule of RSU activity

	Shares			Weighted Average Grant Date Fair Value
Nonvested at January 1, 2022		505,192		$	3.14
Granted		37,765			1.18
Vested		(1,000	)		1.00
Forfeited		–			–
Nonvested at December 31, 2022		541,957		$	3.01